Fecal Microbiome Transplant Trial
Phase 2
56
about 2.2 years
18+
1 site in CA
About this study
This trial is testing whether fecal microbiome transplantation can help remodel the gut bacteria in people with lymphoma that has returned after treatment or not responded to treatment, especially those who have taken high-risk antibiotics. Fecal microbiome transplantation involves transplanting healthy gut bacteria from donors into patients to restore a balanced and protective microbiome. This may improve outcomes for these patients.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive Axicabtagene Ciloleucel
- 2.Take Chemotherapy
- 3.Take Placebo Administration
- +3 more
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
axicabtagene ciloleucel
Secondary: Incidence and severity of Cytokine Release Syndrome, Incidence of adverse events, Overall response rate, Rate of overall survival
diagnostic, therapy
Oncology